Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancers|May 14, 2022
The SARS-CoV-2 Pandemic and Cancer Trials Ireland: Impact, Resolution and LegacySeamus O'Reilly, Verena Murphy, Eibhlin Mulroe, et al.
HRB Open Research|March 15, 2022
Harmonising the human biobanking consent process: an Irish experienceLydia O'Sullivan, Tomás P Carroll, Niamh Clarke, et al.
JCO Clinical Cancer Informatics|April 13, 2023
The Impact of a National Cyberattack Affecting Clinical Trials: The Cancer Trials Ireland ExperienceHarry Harvey, Hailey Carroll, Verena Murphy, et al.
Pharmacoeconomics|February 4, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and SpainJonathan Briody, Ian S Miller, James F O'Mahony, et al.
Oncotarget|June 15, 2017
Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approachBruce Moran, Sudipto Das, Dominiek Smeets, et al.
Cancers|July 26, 2020
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials IrelandCathriona Kearns, Ronan Feighery, John Mc Caffrey, et al.
Nature Communications|June 23, 2026
Spatial analyses implicate high stromal tumour-infiltrating CD8<sup>+</sup> lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancerZak Kinsella, Chowdhury Arif Jahangir, Hannah Nyarkoah Nyarko, et al.
NPJ Genomic Medicine|May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patientsTom Venken, Ian S Miller, Ingrid Arijs, et al.
Digestion|October 19, 2016
Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict InitiativeJohannes Betge, Ana Barat, Verena Murphy, et al.
Plos One|December 18, 2020
Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trialLauren Brady, Brian Hayes, Gráinne Sheill, et al.
Pageof 2